Stryker is trading 22.82% up at $336.77 after rising sharply from the September 21 close of $274.19; no credible overnight catalyst has been identified.
- September 22 coverage identifies no credible overnight announcement, earnings release, acquisition, regulatory action, or analyst event.
- Recent reporting centers on continuing peripheral-vascular manufacturing problems and earlier analyst concerns.
- Broader markets are only modestly mixed.